|Min SIP Amount||Not Supported|
|NAV||₹10.43 (29 Oct 2020)|
|Fund Started||27 Mar 2018|
|Fund Size||₹307 Cr|
|HDFC Bank Ltd.||Financial||Equity||9.4%|
|Reliance Industries Ltd.||Energy||Equity||7.0%|
|Divi's Laboratories Ltd.||Healthcare||Equity||6.6%|
|ICICI Bank Ltd.||Financial||Equity||5.6%|
|Dixon Technologies (India) Ltd.||Engineering||Equity||4.9%|
|Neogen Chemicals Ltd.||Chemicals||Equity||4.4%|
|Colgate-Palmolive (India) Ltd.||FMCG||Equity||4.3%|
|Tata Consultancy Services Ltd.||Technology||Equity||4.0%|
|Rossari Biotech Ltd.||Chemicals||Equity||3.7%|
|Bharti Airtel Ltd.||Communication||Equity||3.2%|
SBI Long Term Advantage Fund Series V Regular Growth is a Equity Mutual Fund Scheme launched by SBI Mutual Fund. This scheme was made available to investors on 27 Mar 2018. R Srinivasan is the Current Fund Manager of SBI Long Term Advantage Fund Series V Regular Growth fund.The fund currently has an Asset Under Management(AUM) of ₹307 Cr and the Latest NAV as of 29 Oct 2020 is ₹10.43.
The SBI Long Term Advantage Fund Series V Regular Growth is rated Moderately High risk.
The scheme seeks to generate capital appreciation over a period of ten years by investing predominantly in equity and equity-related instruments of companies along with income tax benefit.
Upto Rs. 1.5 lac will be tax free under 80C. Lockin of 3 years. Returns will be taxed at 10%.